Recruitment	O
of	O
Minority	B:C0026192
Adolescents	O
and	O
Young	O
Adults	O
into	O
Randomised	O
Clinical	I:C0206035
Trials	I:C0206035
:	O
Testing	O
the	O
Design	O
of	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
Pelvic	O
Inflammatory	I:C0242172
Disease	I:C0242172
Trial	O
.	O

Recruitment	O
of	O
Minority	O
Adolescents	O
and	O
Young	O
Adults	O
into	O
Randomised	B:C0206035
Clinical	I:C0206035
Trials	I:C0206035
:	O
Testing	O
the	O
Design	O
of	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
Pelvic	O
Inflammatory	I:C0242172
Disease	I:C0242172
Trial	O
.	O

Recruitment	O
of	O
Minority	O
Adolescents	O
and	O
Young	O
Adults	O
into	O
Randomised	O
Clinical	I:C0206035
Trials	I:C0206035
:	O
Testing	O
the	O
Design	O
of	O
the	O
Technology	B:C0886296
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
Pelvic	O
Inflammatory	I:C0242172
Disease	I:C0242172
Trial	O
.	O

Recruitment	O
of	O
Minority	O
Adolescents	O
and	O
Young	O
Adults	O
into	O
Randomised	O
Clinical	I:C0206035
Trials	I:C0206035
:	O
Testing	O
the	O
Design	O
of	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
(	O
Technology	B:C0886296
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
Pelvic	O
Inflammatory	I:C0242172
Disease	I:C0242172
Trial	O
.	O

Recruitment	O
of	O
Minority	O
Adolescents	O
and	O
Young	O
Adults	O
into	O
Randomised	O
Clinical	I:C0206035
Trials	I:C0206035
:	O
Testing	O
the	O
Design	O
of	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
Pelvic	B:C0242172
Inflammatory	I:C0242172
Disease	I:C0242172
Trial	O
.	O

Pelvic	B:C0242172
inflammatory	I:C0242172
disease	I:C0242172
(	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
disproportionately	O
affects	O
adolescent	O
and	O
young	O
adult	O
(	O
AYA	O
)	O
women	O
and	O
can	O
negatively	O
influence	O
reproductive	O
health	I:C0242667
trajectories	O
.	O

Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
Pelvic	B:C0242172
inflammatory	I:C0242172
disease	I:C0242172
)	O
disproportionately	O
affects	O
adolescent	O
and	O
young	O
adult	O
(	O
AYA	O
)	O
women	O
and	O
can	O
negatively	O
influence	O
reproductive	O
health	I:C0242667
trajectories	O
.	O

Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
disproportionately	O
affects	O
adolescent	O
and	O
young	O
adult	O
(	O
AYA	O
)	O
women	B:C0043210
and	O
can	O
negatively	O
influence	O
reproductive	O
health	I:C0242667
trajectories	O
.	O

Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
disproportionately	O
affects	O
adolescent	O
and	O
young	O
adult	O
(	O
AYA	O
)	O
women	O
and	O
can	O
negatively	O
influence	O
reproductive	B:C0242667
health	I:C0242667
trajectories	O
.	O

Few	O
randomized	B:C0206035
controlled	I:C0206035
trials	I:C0206035
(	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
)	O
have	O
focused	O
on	O
strategies	O
to	O
improve	O
outpatient	O
adherence	O
or	O
to	O
reduce	O
reproductive	O
morbidity	O
in	O
this	O
population	O
.	O

Few	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
(	O
randomized	B:C0206035
controlled	I:C0206035
trials	I:C0206035
)	O
have	O
focused	O
on	O
strategies	O
to	O
improve	O
outpatient	O
adherence	O
or	O
to	O
reduce	O
reproductive	O
morbidity	O
in	O
this	O
population	O
.	O

Few	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
(	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
)	O
have	O
focused	O
on	O
strategies	O
to	O
improve	B:C0184511
outpatient	O
adherence	O
or	O
to	O
reduce	O
reproductive	O
morbidity	O
in	O
this	O
population	O
.	O

Few	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
(	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
)	O
have	O
focused	O
on	O
strategies	O
to	O
improve	O
outpatient	O
adherence	O
or	O
to	O
reduce	O
reproductive	B:C0035150
morbidity	O
in	O
this	O
population	O
.	O

Few	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
(	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
)	O
have	O
focused	O
on	O
strategies	O
to	O
improve	O
outpatient	O
adherence	O
or	O
to	O
reduce	O
reproductive	O
morbidity	O
in	O
this	O
population	B:C1257890
.	O

This	O
paper	O
describes	O
the	O
research	B:C0086912
methods	I:C0086912
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	O
strategies	O
employed	O
in	O
a	O
novel	O
RCT	O
designed	O
to	O
test	O
a	O
technology	O
-	I:C0886296
enhanced	I:C0886296
community	I:C0886296
-	I:C0886296
health	I:C0886296
nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
intervention	O
among	O
urban	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
.	O

This	O
paper	O
describes	O
the	O
research	O
methods	I:C0086912
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	B:C0886296
strategies	O
employed	O
in	O
a	O
novel	O
RCT	O
designed	O
to	O
test	O
a	O
technology	O
-	I:C0886296
enhanced	I:C0886296
community	I:C0886296
-	I:C0886296
health	I:C0886296
nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
intervention	O
among	O
urban	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
.	O

This	O
paper	O
describes	O
the	O
research	O
methods	I:C0086912
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	O
strategies	O
employed	O
in	O
a	O
novel	O
RCT	B:C0206035
designed	O
to	O
test	O
a	O
technology	O
-	I:C0886296
enhanced	I:C0886296
community	I:C0886296
-	I:C0886296
health	I:C0886296
nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
intervention	O
among	O
urban	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
.	O

This	O
paper	O
describes	O
the	O
research	O
methods	I:C0086912
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	O
strategies	O
employed	O
in	O
a	O
novel	O
RCT	O
designed	O
to	O
test	O
a	O
technology	B:C0886296
-	I:C0886296
enhanced	I:C0886296
community	I:C0886296
-	I:C0886296
health	I:C0886296
nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
intervention	O
among	O
urban	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
.	O

This	O
paper	O
describes	O
the	O
research	O
methods	I:C0086912
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	O
strategies	O
employed	O
in	O
a	O
novel	O
RCT	O
designed	O
to	O
test	O
a	O
technology	O
-	I:C0886296
enhanced	I:C0886296
community	I:C0886296
-	I:C0886296
health	I:C0886296
nursing	I:C0886296
(	O
Technology	B:C0886296
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
intervention	O
among	O
urban	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
.	O

This	O
paper	O
describes	O
the	O
research	O
methods	I:C0086912
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	O
strategies	O
employed	O
in	O
a	O
novel	O
RCT	O
designed	O
to	O
test	O
a	O
technology	O
-	I:C0886296
enhanced	I:C0886296
community	I:C0886296
-	I:C0886296
health	I:C0886296
nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
intervention	B:C0886296
among	O
urban	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
.	O

This	O
paper	O
describes	O
the	O
research	O
methods	I:C0086912
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	O
strategies	O
employed	O
in	O
a	O
novel	O
RCT	O
designed	O
to	O
test	O
a	O
technology	O
-	I:C0886296
enhanced	I:C0886296
community	I:C0886296
-	I:C0886296
health	I:C0886296
nursing	I:C0886296
(	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
)	O
intervention	O
among	O
urban	O
AYA	O
with	O
Pelvic	B:C0242172
inflammatory	I:C0242172
disease	I:C0242172
.	O

AYA	O
women	B:C0043210
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	O
PID	I:C0149959
visits	O
in	O
outpatient	O
clinics	I:C0002424
and	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
to	O
participate	O
in	O
this	O
IRB	O
-	I:C2346499
approved	I:C2346499
trial	O
.	O

AYA	O
women	O
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	B:C0149959
PID	I:C0149959
visits	O
in	O
outpatient	O
clinics	I:C0002424
and	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
to	O
participate	O
in	O
this	O
IRB	O
-	I:C2346499
approved	I:C2346499
trial	O
.	O

AYA	O
women	O
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	O
PID	I:C0149959
visits	B:C1512346
in	O
outpatient	O
clinics	I:C0002424
and	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
to	O
participate	O
in	O
this	O
IRB	O
-	I:C2346499
approved	I:C2346499
trial	O
.	O

AYA	O
women	O
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	O
PID	I:C0149959
visits	O
in	O
outpatient	B:C0002424
clinics	I:C0002424
and	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
to	O
participate	O
in	O
this	O
IRB	O
-	I:C2346499
approved	I:C2346499
trial	O
.	O

AYA	O
women	O
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	O
PID	I:C0149959
visits	O
in	O
outpatient	O
clinics	I:C0002424
and	O
emergency	B:C0562508
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
to	O
participate	O
in	O
this	O
IRB	O
-	I:C2346499
approved	I:C2346499
trial	O
.	O

AYA	O
women	O
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	O
PID	I:C0149959
visits	O
in	O
outpatient	O
clinics	I:C0002424
and	O
emergency	O
departments	I:C0562508
(	O
emergency	B:C0562508
departments	I:C0562508
)	O
to	O
participate	O
in	O
this	O
IRB	O
-	I:C2346499
approved	I:C2346499
trial	O
.	O

AYA	O
women	O
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	O
PID	I:C0149959
visits	O
in	O
outpatient	O
clinics	I:C0002424
and	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
to	O
participate	B:C0030699
in	O
this	O
IRB	O
-	I:C2346499
approved	I:C2346499
trial	O
.	O

AYA	O
women	O
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	O
PID	I:C0149959
visits	O
in	O
outpatient	O
clinics	I:C0002424
and	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
to	O
participate	O
in	O
this	O
IRB	B:C2346499
-	I:C2346499
approved	I:C2346499
trial	O
.	O

Participants	B:C0679646
completed	O
an	O
audio	O
-	O
computerized	O
self	O
-	O
interview	O
(	O
ACASI	O
)	O
,	O
provided	O
vaginal	O
specimens	I:C0586773
,	O
and	O
were	O
randomized	O
to	O
standard	O
treatment	O
or	O
the	O
intervention	O
.	O

Participants	O
completed	O
an	O
audio	O
-	O
computerized	O
self	O
-	O
interview	O
(	O
ACASI	O
)	O
,	O
provided	O
vaginal	B:C0586773
specimens	I:C0586773
,	O
and	O
were	O
randomized	O
to	O
standard	O
treatment	O
or	O
the	O
intervention	O
.	O

Participants	O
completed	O
an	O
audio	O
-	O
computerized	O
self	O
-	O
interview	O
(	O
ACASI	O
)	O
,	O
provided	O
vaginal	O
specimens	I:C0586773
,	O
and	O
were	O
randomized	B:C0034656
to	O
standard	O
treatment	O
or	O
the	O
intervention	O
.	O

Participants	O
completed	O
an	O
audio	O
-	O
computerized	O
self	O
-	O
interview	O
(	O
ACASI	O
)	O
,	O
provided	O
vaginal	O
specimens	I:C0586773
,	O
and	O
were	O
randomized	O
to	O
standard	O
treatment	B:C0087111
or	O
the	O
intervention	O
.	O

Participants	O
completed	O
an	O
audio	O
-	O
computerized	O
self	O
-	O
interview	O
(	O
ACASI	O
)	O
,	O
provided	O
vaginal	O
specimens	I:C0586773
,	O
and	O
were	O
randomized	O
to	O
standard	O
treatment	O
or	O
the	O
intervention	B:C0886296
.	O

Intervention	B:C0886296
participants	O
received	O
text	O
-	O
messaging	O
support	O
for	O
30	O
days	O
and	O
a	O
community	O
health	I:C1522710
nurse	I:C1522710
(	I:C1522710
CHN	I:C1522710
)	I:C1522710
interventionist	I:C1522710
performed	O
a	O
home	O
visit	O
with	O
clinical	O
assessment	O
within	O
5	O
days	O
after	O
enrollment	O
.	O

Intervention	O
participants	B:C0679646
received	O
text	O
-	O
messaging	O
support	O
for	O
30	O
days	O
and	O
a	O
community	O
health	I:C1522710
nurse	I:C1522710
(	I:C1522710
CHN	I:C1522710
)	I:C1522710
interventionist	I:C1522710
performed	O
a	O
home	O
visit	O
with	O
clinical	O
assessment	O
within	O
5	O
days	O
after	O
enrollment	O
.	O

Intervention	O
participants	O
received	O
text	O
-	O
messaging	O
support	O
for	O
30	O
days	O
and	O
a	O
community	B:C1522710
health	I:C1522710
nurse	I:C1522710
(	I:C1522710
CHN	I:C1522710
)	I:C1522710
interventionist	I:C1522710
performed	O
a	O
home	O
visit	O
with	O
clinical	O
assessment	O
within	O
5	O
days	O
after	O
enrollment	O
.	O

Intervention	O
participants	O
received	O
text	O
-	O
messaging	O
support	O
for	O
30	O
days	O
and	O
a	O
community	O
health	I:C1522710
nurse	I:C1522710
(	I:C1522710
CHN	I:C1522710
)	I:C1522710
interventionist	I:C1522710
performed	O
a	O
home	O
visit	O
with	O
clinical	O
assessment	O
within	O
5	O
days	O
after	O
enrollment	B:C1516879
.	O

All	O
patients	O
received	O
a	O
full	O
course	O
of	O
medications	O
and	O
completed	O
research	O
visits	O
at	O
14	O
-	O
days	O
(	O
adherence	O
)	O
,	O
30	O
days	O
and	O
90	O
days	O
with	O
by	O
an	O
outreach	B:C0586969
worker	I:C0586969
.	O

STI	B:C0036916
testing	O
performed	O
at	O
the	O
30	O
-	O
and	O
90	O
-	O
day	O
visits	O
.	O

STI	O
testing	O
performed	O
at	O
the	O
30	O
-	O
and	O
90	O
-	O
day	O
visits	B:C1512346
.	O

Exploratory	B:C0936012
analyses	I:C0936012
using	O
descriptive	O
statistics	I:C1710191
were	O
conducted	O
to	O
examine	O
recruitment	O
,	O
retention	O
,	O
and	O
follow	O
-	I:C1522577
up	I:C1522577
data	O
to	O
test	O
the	O
overall	O
design	O
of	O
the	O
intervention	O
.	O

Exploratory	O
analyses	I:C0936012
using	O
descriptive	B:C1710191
statistics	I:C1710191
were	O
conducted	O
to	O
examine	O
recruitment	O
,	O
retention	O
,	O
and	O
follow	O
-	I:C1522577
up	I:C1522577
data	O
to	O
test	O
the	O
overall	O
design	O
of	O
the	O
intervention	O
.	O

Exploratory	O
analyses	I:C0936012
using	O
descriptive	O
statistics	I:C1710191
were	O
conducted	O
to	O
examine	O
recruitment	O
,	O
retention	O
,	O
and	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
data	O
to	O
test	O
the	O
overall	O
design	O
of	O
the	O
intervention	O
.	O

Exploratory	O
analyses	I:C0936012
using	O
descriptive	O
statistics	I:C1710191
were	O
conducted	O
to	O
examine	O
recruitment	O
,	O
retention	O
,	O
and	O
follow	O
-	I:C1522577
up	I:C1522577
data	O
to	O
test	O
the	O
overall	O
design	O
of	O
the	O
intervention	B:C0886296
.	O

In	O
the	O
first	O
48	O
months	O
,	O
64	O
%	O
of	O
463	O
patients	O
were	O
eligible	O
for	O
the	O
study	O
and	O
81.2	O
%	O
of	O
293	O
eligible	O
patients	O
were	O
recruited	O
for	O
the	O
study	O
(	O
63.3	O
%	O
)	O
;	O
238	O
(	O
81.2	O
%	O
)	O
of	O
eligible	O
patients	O
were	O
enrolled	B:C1516879
.	O

Most	O
participants	B:C0679646
were	O
African	O
American	I:C0085756
(	O
95.6	O
%	O
)	O
with	O
a	O
mean	O
age	O
of	O
18.6	O
(	O
2.3	O
)	O
.	O

Most	O
participants	O
were	O
African	B:C0085756
American	I:C0085756
(	O
95.6	O
%	O
)	O
with	O
a	O
mean	O
age	O
of	O
18.6	O
(	O
2.3	O
)	O
.	O

Ninety	O
-	O
four	O
percent	O
of	O
individuals	B:C0027361
assigned	O
to	O
the	O
TECH-N	O
intervention	I:C0886296
completed	O
the	O
nursing	O
visits	O
.	O

Ninety	O
-	O
four	O
percent	O
of	O
individuals	O
assigned	O
to	O
the	O
TECH-N	B:C0886296
intervention	I:C0886296
completed	O
the	O
nursing	O
visits	O
.	O

All	O
completed	O
visits	O
have	O
been	O
within	O
the	O
5	O
-	O
day	O
window	O
and	O
over	O
90	O
%	O
of	O
patients	O
in	O
both	O
arms	O
have	O
been	O
retained	O
over	O
the	O
3	O
-	O
month	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
period	O
.	O

Biological	O
data	O
suggests	O
a	O
shift	O
in	O
the	O
biological	O
milieu	O
with	O
the	O
predominance	O
of	O
Chlamydia	B:C0518948
trachomatis	I:C0518948
,	O
Mycoplasma	O
genitalium	I:C3854370
,	O
and	O
Trichomonas	O
vaginalis	I:C0040923
infections	I:C0040923
.	O

Biological	O
data	O
suggests	O
a	O
shift	O
in	O
the	O
biological	O
milieu	O
with	O
the	O
predominance	O
of	O
Chlamydia	O
trachomatis	I:C0518948
,	O
Mycoplasma	B:C3854370
genitalium	I:C3854370
,	O
and	O
Trichomonas	O
vaginalis	I:C0040923
infections	I:C0040923
.	O

Biological	O
data	O
suggests	O
a	O
shift	O
in	O
the	O
biological	O
milieu	O
with	O
the	O
predominance	O
of	O
Chlamydia	O
trachomatis	I:C0518948
,	O
Mycoplasma	O
genitalium	I:C3854370
,	O
and	O
Trichomonas	B:C0040923
vaginalis	I:C0040923
infections	I:C0040923
.	O

Preliminary	O
data	O
from	O
the	O
Technology	B:C0886296
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	B:C0442529
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	B:C1331016
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	B:C0026192
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	B:C0242172
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	B:C0030699
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	B:C0242667
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	B:C0206035
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	O
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Preliminary	O
data	O
from	O
the	O
Technology	O
Enhanced	I:C0886296
Community	I:C0886296
Health	I:C0886296
Nursing	I:C0886296
study	O
demonstrated	O
that	O
urban	O
,	O
low	O
-	I:C1331016
income	I:C1331016
,	O
minority	O
AYA	O
with	O
Pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	O
in	O
sexual	O
and	O
reproductive	O
health	I:C0242667
randomized	O
controlled	I:C0206035
trials	I:C0206035
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	B:C1514880
of	I:C1514880
the	I:C1514880
study	I:C1514880
.	O

Community	O
-	O
based	O
sexual	O
health	O
interventions	B:C0184661
appear	O
to	O
be	O
both	O
feasible	O
and	O
acceptable	O
in	O
this	O
population	O
.	O

Community	O
-	O
based	O
sexual	O
health	O
interventions	O
appear	O
to	O
be	O
both	O
feasible	O
and	O
acceptable	O
in	O
this	O
population	B:C1257890
.	O

